A case of recurrent advanced colon cancer treated with CPT-11 for second-line chemotherapy

S. Kawabe, H. Takiuchi, I. Hirata, Y. Takao, K. Nakagawa, Y. Egashira, Y. Nakagawa, K. Katsu

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A 59-year old male patient had been operated on for sigmoid colon cancer in July, 1990. Operative findings were P0, H0, S1, N (-), Stage I, and histological findings were ss, ly 2, v O, n (-). In July 1994, the CEA level elevated, and he was diagnosed as having para-aortic LN swelling and stenosis of anastomosis of colon. He was admitted for treatment of recurrent colon cancer. Initially, he was treated with continuous injection of 5-FU, low- dose CDDP and Leucovorin. His CEA level decreased and para-aortic LN diminished in size. But, in December 1995, the CEA level and para-aortic LN relapsed. 5-FU, CDDP and Leucovorin were administered, but the CEA level became more and more elevated. This regimen was not considered responsible for drug resistance. CPT-11 was administered at 60 mg/week 6 times, and 80 mg/week 3 times. The side effects disappeared, LN sightly diminished in size, and the CEA level decreased. Judging by the anticancer effect without severe side effect, we found CPT-11 a useful drug for second-line chemotherapy.

Original languageEnglish
Pages (from-to)1315-1319
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Issue number10
Publication statusPublished - 1997
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'A case of recurrent advanced colon cancer treated with CPT-11 for second-line chemotherapy'. Together they form a unique fingerprint.

Cite this